Technology
iRobot Reports First Quarter 2025 Financial Results
Published
1 year agoon
By
Global New Product Rollout Continues with High-Impact Launch Events
Company Continues to Execute “iRobot Elevate” Turnaround Strategy
BEDFORD, Mass., May 6, 2025 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the first quarter ended March 29, 2025.
“We continued to make meaningful progress on our iRobot Elevate turnaround strategy in the first quarter and initiated the largest new product launch in iRobot’s history,” said Gary Cohen, iRobot CEO. “We are encouraged by the positive reactions from distributors, retailers and consumers, and expect to see an uptick in sales later in the year as availability of our suite of new, technologically innovative Roomba® vacuums and 2-in-1 vacuums and mops expands. As our Board of Directors continues its review of strategic alternatives for our business, we remain focused on executing our proven strategy and delivering the products our customers have come to know and love.”
The Company has achieved a significant reduction in operating expenses and production costs by transforming its R&D and supply chain model to better leverage the Company’s design capabilities and contract manufacturing partnerships. This reinvention of the way iRobot operates has allowed for a greater focus on innovation and improvements to product features, quality, and software. With respect to the current tariff conditions, the majority of the Company’s U.S. imports come from Vietnam and are currently subject to a 10% tariff rate.
“Our first quarter performance reflects what has been a major transitional period for iRobot as we worked to clear our sales channels of legacy product inventory. As we continue to navigate a dynamic macro environment, we expect our new products and lower overall cost structure to drive improved profitability over the long term. We expect to see solid sales traction later this year to support year-over-year revenue growth in 2025, and we remain on track to deliver gross-margin expansion and improved cash flow from operations this year,” concluded Cohen.
Marketing Highlights
In late March and early April 2025, iRobot announced the availability in North America and select European markets its suite of technologically innovative Roomba® vacuums and 2-in-1 vacuums and mops. Media coverage in North America and Europe was impressive with more than 200 pieces of media coverage in some of the world’s most influential tech/consumer outlets, reaching a potential audience (total UVPM/Circulation/Reach) of more than 2.5 billion.On April 16, 2025, iRobot introduced its new product lineup in Japan, engaging with more than 100 media outlets and influencers, resulting in more than 600 pieces of media coverage in one week.On April 23, 2025, iRobot announced the availability of the Roomba® Max 705 Vac Robot + AutoEmpty™ Dock in North America and select European markets.iRobot has continued to receive positive media coverage and product reviews around the world, including in Tom’s Guide US, Engadget US, Vacuum Wars US, The Independent UK, La Voz de Galicia Spain, Les Numeriques France, Fuji News Network and All the Things.
First Quarter 2025 Financial Results (in millions, except per share amounts and percentages)
Q1 2025
Q1 2024
Revenue
$101.6
$150.0
GAAP Gross Margin
20.0 %
24.1 %
Non-GAAP Gross Margin
22.0 %
24.6 %
GAAP Operating Expenses
$66.1
$24.2
Non-GAAP Operating Expenses
$53.8
$76.9
GAAP Operating (Loss) Income*
($45.8)
$11.9
Non-GAAP Operating Loss
($31.5)
($40.0)
GAAP Net (Loss) Income*
($87.3)
$8.6
Non-GAAP Net Loss
($60.0)
($43.0)
GAAP Net (Loss) Income Per Share*
($2.84)
$0.30
Non-GAAP Net Loss Per Share
($1.95)
($1.53)
*Q1 2024 GAAP operating income, GAAP net income and GAAP net income per share included the one-time net termination fee of $75 million received as a result of the termination of the Amazon Merger Agreement.
Additional Financial Highlights
As of March 29, 2025, the Company’s cash and cash equivalents including restricted cash totaled $112.3 million, compared with $138.0 million at the end of the fourth quarter of 2024. During the third quarter of 2024, the Company elected to draw down $40 million from the restricted cash that is set aside for future repayment of its term loan, subject to limited ability of the Company to utilize such amount at the discretion of the lenders for the purchase of inventory. The Company repaid that amount to restricted cash during the first quarter of 2025.As of March 29, 2025, the Company reduced inventory to $69.0 million, compared with $76.0 million at the end of the fourth quarter of 2024.In the first quarter of 2025, revenue decreased 39.9% in the U.S., 26.9% in EMEA, and 20.8% in Japan, respectively, over the prior-year period. Excluding the unfavorable foreign currency impact, Japan revenue decreased 10% and EMEA revenue decreased 24% over the prior-year period. Q1 2025 revenue was impacted by additional promotional spending to stimulate sell-through of legacy products ahead of the Company’s 2025 new product launch, along with ongoing competitive challenges that the Company is addressing with its new product launches.Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 76% of total robot sales in the first quarter of 2025, compared with 81% in the same period last year.
Ongoing Strategic Review
As previously announced, the Company’s Board of Directors is conducting a review of strategic alternatives, including, but not limited to, exploring a potential sale or strategic transaction, and refinancing the Company’s debt. This review process is ongoing.
The Board has not set a timetable for the conclusion of this review, and there can be no assurance that the exploration of strategic alternatives will result in any transactions or outcomes. The Company does not intend to disclose developments relating to this process until it determines that further disclosure is appropriate or necessary.
The Company remains actively engaged in ongoing collaborative and constructive discussions with its primary lender while the Board continues its strategic review process. On April 30, 2025, the Company further amended its existing term loan to extend the covenant waiver under the term loan to June 6, 2025.
In light of the ongoing strategic review, the Company will not be hosting a first quarter 2025 results earnings conference call and webcast, and will not be providing a 2025 outlook at this time.
About iRobot Corp.
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 50 million robots worldwide. iRobot’s product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company’s expectations regarding the financial profile and impact of newly launched products in 2025; expectations regarding improved profitability; expectations regarding 2025 product sales and related revenue growth, achievement of gross margin expansion and improved cash flow from operations; the Board’s review of strategic alternatives for the business; and the Company’s business plans and strategies and the anticipated impact thereof. These forward-looking statements are based on the Company’s current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company’s ability to obtain capital when desired on favorable terms, if at all; (ii) the Company’s ability to realize the benefits of its operational restructuring; (iii) the impact of various global conflicts on the Company’s business and general economic conditions; (iv) the Company’s ability to implement its business strategy; (v) the risk that disruptions from the operational restructuring will harm the Company’s business, including current plans and operations; (vi) the ability of the Company to retain and hire key personnel; (vii) legislative, regulatory and economic developments affecting the Company’s business; (viii) general economic and market developments and conditions; (ix) the evolving legal, regulatory and tax regimes under which the Company operates; (x) potential business uncertainty, including changes to existing business relationships that could affect the Company’s financial performance; (xi) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xii) current supply chain challenges; (xiii) the financial strength of our customers and retailers; (xiv) the impact of any applicable tariffs on goods imported into the United States; (xv) competition; and (xvi) the results and impact of the Board’s strategic review of alternatives for the business, as well as the Company’s response to any of the aforementioned factors. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
iRobot Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
For the three months ended
March 29, 2025
March 30, 2024
Revenue
$ 101,569
$ 150,014
Cost of revenue:
Cost of product revenue
79,598
113,913
Restructuring and other
1,658
–
Total cost of revenue
81,256
113,913
Gross profit
20,313
36,101
Operating expenses:
Research and development
14,686
33,878
Selling and marketing
26,051
29,716
General and administrative
19,016
(53,711)
Restructuring and other
6,174
14,146
Amortization of acquired intangible assets
136
172
Total operating expenses
66,063
24,201
Operating (loss) income
(45,750)
11,900
Other expense, net
(41,066)
(3,185)
(Loss) income before income taxes
(86,816)
8,715
Income tax expense
457
108
Net (loss) income
$ (87,273)
$ 8,607
Net (loss) income per share:
Basic
$ (2.84)
$ 0.31
Diluted
$ (2.84)
$ 0.30
Number of shares used in per share calculations:
Basic
30,725
28,171
Diluted
30,725
28,266
Stock-based compensation included in above figures:
Cost of revenue
346
828
Research and development
910
2,897
Selling and marketing
965
1,338
General and administrative
3,093
2,885
Total
$ 5,314
$ 7,948
iRobot Corporation
Condensed Consolidated Balance Sheets
(unaudited, in thousands)
March 29, 2025
December 28, 2024
Assets
Cash and cash equivalents
$ 69,922
$ 134,303
Restricted cash
40,003
1,259
Accounts receivable, net
30,804
49,865
Inventory
68,968
76,029
Other current assets
24,588
27,046
Total current assets
234,285
288,502
Property and equipment, net
12,106
15,835
Operating lease right-of-use assets
13,675
14,322
Deferred tax assets
9,980
9,817
Goodwill
171,548
167,288
Intangible assets, net
3,225
3,212
Other assets
16,690
17,161
Total assets
$ 461,509
$ 516,137
Liabilities and stockholders’ (deficit) equity
Accounts payable
$ 97,298
$ 106,367
Accrued expenses
96,761
100,597
Deferred revenue and customer advances
9,794
11,280
Term loan
224,084
–
Total current liabilities
427,937
218,244
Term loan
–
200,604
Operating lease liabilities
20,348
21,598
Other long-term liabilities
14,017
14,452
Total long-term liabilities
34,365
236,654
Total liabilities
462,302
454,898
Stockholders’ (deficit) equity
(793)
61,239
Total liabilities and stockholders’ (deficit)
equity
$ 461,509
$ 516,137
iRobot Corporation
Consolidated Statements of Cash Flows
(unaudited, in thousands)
For the three months ended
March 29, 2025
March 30, 2024
Cash flows from operating activities:
Net (loss) income
$ (87,273)
$ 8,607
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization
2,623
5,812
Loss on equity investment
–
375
Stock-based compensation
5,314
7,948
Provision for inventory excess and obsolescence
384
200
Change in fair value of term loan
25,965
(1,008)
Debt issuance costs expensed under fair value option
11,614
239
Deferred income taxes, net
292
(127)
Other
1,638
(3,452)
Changes in operating assets and liabilities — (use) source
Accounts receivable
20,156
38,565
Inventory
7,434
16,066
Other assets
3,135
6,045
Accounts payable
(9,642)
(74,601)
Accrued expenses and other liabilities
(8,100)
(3,232)
Net cash (used in) provided by operating activities
(26,460)
1,437
Cash flows from investing activities:
Additions of property and equipment
–
(118)
Purchase of investments
(8)
–
Net cash used in investing activities
(8)
(118)
Cash flows from financing activities:
Income tax withholding payment associated with restricted stock vesting
(84)
(390)
Proceeds from issuance of common stock, net of issuance costs
–
5,632
Repayment of term loan
–
(34,947)
Payment of debt issuance costs
–
(239)
Net cash used in financing activities
(84)
(29,944)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
922
882
Net decrease in cash, cash equivalents and restricted cash
(25,630)
(27,743)
Cash, cash equivalents and restricted cash, at beginning of period
137,951
187,887
Cash, cash equivalents and restricted cash, at end of period
$ 112,321
$ 160,144
Cash, cash equivalents and restricted cash, at end of period:
Cash and cash equivalents
$ 69,922
$ 118,356
Restricted cash
40,003
40,012
Restricted cash, non-current (included in other assets)
2,396
1,776
Cash, cash equivalents and restricted cash, at end of period
$ 112,321
$ 160,144
iRobot Corporation
Supplemental Information
(unaudited)
For the three months ended
March 29, 2025
March 30, 2024
Revenue by Geographical Region *
United States
$ 41,440
$ 68,896
EMEA
32,947
45,088
Japan
21,949
27,718
Other
5,233
8,312
Total
$ 101,569
$ 150,014
Robot Units Shipped *
Solo and other
98
267
2-in-1
312
189
Total
410
456
Revenue by Product Category **
Solo and other
$ 36
$ 94
2-in-1
66
56
Total
$ 102
$ 150
Average gross selling prices for robot units
$ 296
$ 346
Headcount
530
1,058
* in thousands
** in millions
Certain numbers may not total due to rounding
iRobot Corporation
Explanation of Non-GAAP Measures
In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.
Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Amortization of Acquired Intangible Assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures, including with respect to the iRobot-Amazon Merger. It also includes business combination adjustments including adjustments after the measurement period has ended. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.
Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.
Debt Issuance Costs: Debt issuance costs include various incremental fees paid to third parties and warrants issued in connection with the issuance or amendment of debt. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Income Tax Adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowances based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.
iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals
(in thousands, except per share amounts)
(unaudited)
For the three months ended
March 29, 2025
March 30, 2024
GAAP Revenue
$ 101,569
$ 150,014
GAAP Gross Profit
$ 20,313
$ 36,101
Stock-based compensation
346
828
Restructuring and other
1,658
–
Non-GAAP Gross Profit
$ 22,317
$ 36,929
GAAP Gross Margin
20.0 %
24.1 %
Non-GAAP Gross Margin
22.0 %
24.6 %
GAAP Operating Expenses
$ 66,063
$ 24,201
Amortization of acquired intangible assets
(136)
(172)
Stock-based compensation
(4,968)
(7,120)
Net merger, acquisition and divestiture (expense) income
(949)
74,117
Restructuring and other
(6,174)
(14,146)
Non-GAAP Operating Expenses
$ 53,836
$ 76,880
GAAP Operating Expenses as a % of GAAP Revenue
65.0 %
16.1 %
Non-GAAP Operating Expenses as a % of Non-GAAP Revenue
53.0 %
51.2 %
GAAP Operating (Loss) Income
$ (45,750)
$ 11,900
Amortization of acquired intangible assets
136
172
Stock-based compensation
5,314
7,948
Net merger, acquisition and divestiture expense (income)
949
(74,117)
Restructuring and other
7,832
14,146
Non-GAAP Operating Loss
$ (31,519)
$ (39,951)
GAAP Operating Margin
(45.0) %
7.9 %
Non-GAAP Operating Margin
(31.0) %
(26.6) %
iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued
(in thousands, except per share amounts)
(unaudited)
For the three months ended
March 29, 2025
March 30, 2024
GAAP Income Tax Expense
$ 457
$ 108
Tax effect of non-GAAP adjustments
48
601
Other tax adjustments
(131)
(192)
Non-GAAP Income Tax Expense
$ 374
$ 517
GAAP Net (Loss) Income
$ (87,273)
$ 8,607
Amortization of acquired intangible assets
136
172
Stock-based compensation
5,314
7,948
Net merger, acquisition and divestiture expense (income)
949
(74,117)
Restructuring and other
7,832
14,146
Loss on strategic investments
–
375
Debt issuance costs
13,009
239
Income tax effect
83
(409)
Non-GAAP Net Loss
$ (59,950)
$ (43,039)
GAAP Net (Loss) Income Per Diluted Share
$ (2.84)
$ 0.30
Amortization of acquired intangible assets
0.01
0.01
Stock-based compensation
0.17
0.28
Net merger, acquisition and divestiture expense (income)
0.03
(2.63)
Restructuring and other
0.26
0.50
Loss on strategic investments
–
0.01
Debt issuance costs
0.42
0.01
Income tax effect
–
(0.01)
Non-GAAP Net Loss Per Diluted Share
$ (1.95)
$ (1.53)
Number of shares used in diluted per share calculation
30,725
28,171
Supplemental Information
Days sales outstanding
28
24
GAAP Days in inventory
77
107
Non-GAAP Days in inventory(1)
79
108
(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days.
View original content to download multimedia:https://www.prnewswire.com/news-releases/irobot-reports-first-quarter-2025-financial-results-302447738.html
SOURCE iRobot Corporation
You may like
Technology
BlueNexus Technologies Unveils AquaX Hub at SIWW 2026 — AI Autonomous Operations Extended to Legacy Water Assets
Published
3 hours agoon
June 21, 2026By
SINGAPORE, June 21, 2026 /PRNewswire/ — At Singapore International Water Week (SIWW) 2026, BlueNexus Technologies unveiled the global debut of AquaX Hub™ — a compact plug-and-play edge device that brings full AI-powered autonomous operation to standalone water equipment and legacy treatment plants. The launch drew sustained engagement from utilities, industrial operators and engineering firms.
The water sector confronts converging pressures: aging infrastructure, a critical shortage of skilled technicians, and relentless operational cost escalation. AquaX Hub™ answers these directly — extending the AI autonomous operation already proven plant-wide by AquaX Robot™ to a single asset, and delivering comparable monitoring and operational management without a control-system overhaul.
“The industry cannot hire its way out of this problem,” said Jack Zhang, CEO of BlueNexus Technologies. “AI autonomous operation is no longer a future concept — the barrier to entry is gone.”
The AquaX Ecosystem
BlueNexus has built the industry’s first fully integrated AI autonomous water operation platform, spanning three complementary pillars:
AquaX Robot™ is the flagship plant-wide AI agent, built on large language models with proprietary vision, acoustic and infrared multimodal sensing. It optimizes treatment processes 24/7 and predicts equipment failures. Live deployments show up to 90% reduction in on-site staffing, a 50% drop in equipment breakdowns, and approximately 35% lower O&M costs.
AquaX Hub™, making its global debut at SIWW 2026, is a lightweight edge terminal extending that capability to any water system. With an independent local processing module, it monitors and inspects equipment through multimodal sensing and runs a self-contained processing loop. The device integrates seamlessly with existing SCADA, cloud and enterprise platforms via standardized APIs.
i-WaterHub™, the company’s standardized modular treatment plant, operated autonomously by AquaX Robot, delivers 2,500 to 40,000 m³/day for municipal and industrial applications.
Market Momentum
SIWW 2026 convened nearly 500 exhibitors from over 65 countries. BlueNexus has identified priority markets for AquaX Hub™ in Southeast Asia, the Middle East and Africa. “The conversations this week have already translated into concrete business opportunities and we expect rapid deployment in the coming months.” Zhang confirmed.
About BlueNexus Technologies
BlueNexus Technologies is a Singapore-based water-technology company building intelligent, AI-operated systems for the world’s most water-intensive industries. We design and deliver modular water treatment infrastructure that is smarter to run, faster to deploy, and built to operate autonomously.
Web: www.bluenexus.tech
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bluenexus-technologies-unveils-aquax-hub-at-siww-2026–ai-autonomous-operations-extended-to-legacy-water-assets-302805849.html
SOURCE BlueNexus Technologies
Technology
VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published
11 hours agoon
June 20, 2026By
With the presence of Emmanuel Macron and Narendra Modi, Prime Minister of India
PARIS, June 20, 2026 /CNW/ — From June 17 to 20, 2026 at Paris Porte de Versailles, VivaTech celebrated its 10th edition, surpassing the exceptional milestone of 200,000 visitors from 165 nationalities, with more than 15,000 startups present, 1,155 speakers and over 5 billion cumulative impressions on social media. Europe’s largest tech and innovation event has reached a new dimension, consolidating its status as an unmissable global gathering.
Exceptional speakers
VivaTech welcomed the greatest figures in global tech: Jeff Bezos (Amazon & Blue Origin), Dave Limp (Blue Origin), Bernard Arnault (LVMH), Henna Virkkunen (European Commission), Ekaterina Zaharieva (European Commission). Germany, Country of the Year 2026, was represented by a ministerial delegation, while India, AI Country Partner 2026, was led by Prime Minister Narendra Modi, as a continuation of the AI Summit in New Delhi.
Innovation and business at the heart of the event
More than 4,500 exhibitors, 61% of whom were international, showcased their latest innovations. Among the standout innovations: the smart contact lens by XPANCEO, the thought-controlled humanoid robot by Unitree x HABS, and the 3D-printed resorbable implants by Lattice Medical. New formats such as the Business Plaza and Investors Office Hours further accelerated business connections.
The VivaTech x Bloomberg Awards
For the first time, VivaTech presented the VivaTech x Bloomberg Awards, recognising the most influential figures in global tech, including Sir Tim Berners-Lee (Visionary Award), Joe Tsai (Leadership Award) and Yann LeCun (Momentum Award).
Innovation open to all
VivaTech also took over the Champs-Élysées on June 14th for an open-air technology showcase, before opening its doors to the general public on June 20th with astronaut Thomas Pesquet as guest star.
“This 10th edition was not a celebration of the 9 previous years, but the opening of a new decade full of promise.” — Maurice Lévy, Michèle Benbunan & François Bitouzet, VivaTech
See you from June 16 to 19, 2027 at Paris Expo Porte de Versailles for VivaTech 2027!
About VivaTech
VivaTech accelerates innovation by connecting startups, tech leaders, major companies, and investors responding to our world’s biggest challenges.
Each year, over four exciting days in Paris, VivaTech creates Europe’s biggest startup and tech event, exploring the most disruptive topics in tech with world-premiere demos, launches, and conferences in a collaborative ecosystem. This is where business meets innovation. Join us for the eleventh edition of VivaTech 16-19 June 2027.
For more information go to our website at https://vivatech.com/media or follow us on social media @VivaTech.
Contact
press@vivatechnology.com
Logo: https://mmx.prnewswire.com/media/MS1865564/VT_LOGO_EN.jpg
Photo : https://mmx.prnewswire.com/media/MS1869778/VivaTech_2026.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/vivatech-2026-celebrates-its-10th-anniversary-with-a-record-edition-surpassing-200-000-visitors-302805827.html
SOURCE VivaTech
Technology
Pope Leo XIV embraces paediatric patients at CNAO in Pavia
Published
14 hours agoon
June 20, 2026By
PAVIA, Italy, June 20, 2026 /PRNewswire/ — The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV’s pastoral visit to the city of Pavia. His choice to begin his journey at this center reflects a profound commitment to fostering meaningful dialogue between advanced scientific progress and the alleviation of human suffering.
CNAO President Gianluca Vago and General Manager Sandro Rossi received His Holiness, illustrating the center’s distinctive capabilities. CNAO stands out as a unique reality in Italy, remaining one of the very few facilities worldwide capable of delivering hadrontherapy using both protons and carbon ions. The technological core of the facility is its synchrotron, a subatomic particle accelerator that generates ultra-high-precision beams to treat complex, inoperable and radioresistant tumours. This cutting-edge technology allows for the targeted eradication of diseased cells while meticulously preserving surrounding healthy tissues, drastically improving patients’ survival and quality of life.
Furthermore, CNAO is expanding its capabilities as a premier multi-center utilizing new ion species, like Helium, later Oxygen and Neon. Soon, treatments will incorporate the Leo Cancer Care upright positioning and imaging system. The immediate future also includes beginning therapies with a Hitachi dedicated proton accelerator and gantry and a BNCT system for metastatic diseases, equipped with an electrostatic accelerator produced by TAE Life Science. With these new technologies, CNAO will become one of the most technologically advanced center in the world.
To date, over six thousand individuals, including approximately three hundred children and adolescents, have benefited from these life-saving treatments.
During his visit, the Pope engaged with CNAO’s Board of Directors, a collaborative body uniting national universities, clinical institutions, and research centers. He also extended his heartfelt greetings to the two hundred employees of the center. These doctors, physicists, engineers, and researchers tirelessly operate the advanced technologies in the service of oncology patients.
The emotional pinnacle of the day was the Holy Father’s private gathering with a delegation of young children who underwent treatment. The paediatric patients and their families shared a deeply touching moment of closeness, receiving the Pope’s comforting embrace.
“The visit of Pope Leo XIV honours us and represents a moment of extraordinary human value”, stated CNAO President Gianluca Vago. “In his encyclical Magnifica Humanitas, the Holy Father emphasizes the necessity of a science that constantly safeguards the centrality of the person and directs technology toward the common good. In a time marked by global tensions, CNAO testifies daily how the incredible power of the atom can be used not to destroy, but to heal. The particle beams we utilize against disease are, symbolically, Rays of Hope, sharing and supporting the IAEA project bearing this name. The embrace the Holy Father reserved for our children reminds us that scientific research finds its most authentic purpose when it encounters listening, compassion, and hope”.
Photo – https://mma.prnewswire.com/media/2997869/Papa_al_Cnao_crediti_Andrea_Perotti.jpg
Logo – https://mma.prnewswire.com/media/2997643/CNAO_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pope-leo-xiv-embraces-paediatric-patients-at-cnao-in-pavia-302805799.html
Bitcoin ETFs shed a record $6.4B in 30 days amid crypto winter chill
BlueNexus Technologies Unveils AquaX Hub at SIWW 2026 — AI Autonomous Operations Extended to Legacy Water Assets
Notorious ‘sandwich attack’ bot Jaredfromsubway.eth exploited for $7.5M
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoJBD Launches Roadrunner II Polychrome MicroLED Projector Based on Its 2.5 μm Pixel-Pitch Platform
-
Coin Market5 days agoSolana treasury firms resist Forward Industries’ consolidation push
-
Coin Market4 days agoIllinois governor approves crypto transaction tax despite industry uproar
-
Technology5 days agoIneffable Intelligence Selects Google Cloud To Power Its Superintelligence Mission
-
Technology4 days agoGLOBAL CONSUMER RWA SUMMIT 2026 Successfully Held at Hong Kong Science Park
-
Coin Market5 days agoBitcoin doesn’t need Ethereum-style yield, says Strategy’s Michael Saylor
-
Coin Market5 days agoBitcoin sell-off toward $60K may resume as Japan hikes interest rates
-
Coin Market5 days agoSpaceX’s debut: A win for crypto price discovery, a fail for tokenized access
